Homepage - CRTOnline

TCT 2020 Goes Virtual

TCT 2020 Goes Virtual

TAVR Appears to Be Reasonable Treatment for Higher-Risk Patients with Bicuspid Aortic Stenosis

TAVR Appears to Be Reasonable Treatment for Higher-Risk Patients with Bicuspid Aortic Stenosis

DCBs Show Good Results in BMS-ISR, Less Effective in DES-ISR

DCBs Show Good Results in BMS-ISR, Less Effective in DES-ISR https://www.crtonline.org/news-detail/dcbs-show-good-results-in-bms-isr-less-effective-i

Study Finds No Benefit of Hydroxychloroquine or Chloroquine in COVID-19 Treatment

Study Finds No Benefit of Hydroxychloroquine or Chloroquine in COVID-19 Treatment https://www.crtonline.org/news-detail/study-finds-no-benefit-of-hydroxychloroquine-chlor

Complete Revascularization Tops Culprit-Lesion-Only Strategy in Systematic Review

Complete Revascularization Tops Culprit-Lesion-Only Strategy in Systematic Review https://www.crtonline.org/news-detail/complete-revascularization-tops-culprit-lesion-onl

In The News See More

TAVR Appears to Be Reasonable Treatment for Higher-Risk Patients with Bicuspid Aortic Stenosis

by
Jason Wermers, CRTonline.org

Consensus Document Endorses DCBs to Treat Coronary Artery Disease

by
Charan Yerasi, CRTonline.org

TCT 2020 Goes Virtual

by
Jason Wermers, CRTonline.org

DCBs Show Good Results in BMS-ISR, Less Effective in DES-ISR

by
Brian Forrestal, CRTOnline.org

Study Finds No Benefit of Hydroxychloroquine or Chloroquine in COVID-19 Treatment

by
Jason Wermers, CRTonline.org

Complete Revascularization Tops Culprit-Lesion-Only Strategy in Systematic Review

by
Brian C. Case, CRTonline.org

Type A Aortic Dissection Cases Decrease, Deaths Rise in NYC During COVID-19 Pandemic

by
Chava Chezar-Azerrad, CRTonline.org

Study: Intravenous Alteplase Adds No Benefit to Endovascular Thrombectomy in Treating Stroke

by
Charan Yerasi, CRTonline.org

Small Study Shows Immune Globulin May Treat COVID-19-Related Children’s Inflammatory Syndrome

by
Jason Wermers, CRTonline.org
COVID-19's Impact on Fellowship with Evan Shlofmitz, Jay Mohan, and Gaurav Rao

COVID-19 Series: Focused Discussions View More

Impact on Research – The Global Perspective with Dr. Pieter Kappetein

May 20, 2020

CDRH during COVID-19 with Drs. Farb, Kalb, Waksman, & Zuckerman

May 14, 2020

Covid-19 & Racial Disparities with Drs. Batchelor, Collins, Horne, and Williams

May 07, 2020

One on One with Tim Henry: Where are the STEMI Cases?

May 05, 2020

$Management of Acute Myocardial Infraction During COVID-19 Pandemic$

Management of Acute Myocardial Infraction During COVID-19 Pandemic

May 05, 2020

COVID-19 & Journals - An International View with Davide Capodanno

May 05, 2020

Novel therapy for treatment of hypertension

Latest Videos See All Interviews »

Incidence, Predictors and Outcomes of Acute Kidney Injury in Patients Undergoing Transcatheter Aortic Valve Replacement: Insights from the ...

Mar 10, 2020

Innovations from Israel

Mar 10, 2020

Update on the Alta Valve

Apr 09, 2020

How to Increase Your Patient's Knowledge and Volume with Regards to LAA Closure?

Mar 09, 2020

Twilight: Should We Drop Aspirin

Mar 09, 2020

Anticoagulation Versus Antiplatelet Therapy After Transcatheter Aortic Valve Replacement in Low Risk Patients

Apr 09, 2020

Journal Watch More »
The Effect of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibition on the Risk of Venous Thromboembolism

May 26, 2020 by
N Marston, et al.; Circ 2020; 141:1600-07

The Effect of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibition on the Risk of Venous Thromboembolism

Risk/Benefit Tradeoff of Antithrombotic Therapy in Patients With Atrial Fibrillation Early and Late After an Acute Coronary Syndrome or Percutaneous Coronary Intervention. Insights From AUGUSTUS

May 21, 2020 by
J Alexander, et al.; Circ 2020; 141:1618-27

Risk/Benefit Tradeoff of Antithrombotic Therapy in Patients With Atrial Fibrillation Early and Late After an Acute Coronary Syndrome or Percutaneous Coronary Intervention. Insights From AUGUSTUS

Peripheral Artery Disease and Venous Thromboembolic Events After Acute Coronary Syndrome. Role of Lipoprotein(a) and Modification by Alirocumab: Prespecified Analysis of the ODYSSEY OUTCOMES Randomize

May 21, 2020 by
G Schwartz, et al.; Circ 2020; 141:1608-17

Peripheral Artery Disease and Venous Thromboembolic Events After Acute Coronary Syndrome. Role of Lipoprotein(a) and Modification by Alirocumab: Prespecified Analysis of the ODYSSEY OUTCOMES Randomized Clinical Trial

Associations Between Cardiovascular Risk, Structural Brain Changes, and Cognitive Decline

May 21, 2020 by
Ruixue Song, Hui Xu, Christina S. Dintica, Kuan-Yu Pan, ... Weili Xu

Associations Between Cardiovascular Risk, Structural Brain Changes, and Cognitive Decline

Evaluation and Management of Nonculprit Lesions in STEMI

May 21, 2020 by
Troels Thim, Nina W. van der Hoeven, Carmine Musto, Robin Nijveldt, Matthias Götberg, Thomas Engstrøm, Pieter C. Smits, Keith G. Oldroyd, Anthony H. Gershlick, Javier Escaned, Sergio Bravo Baptista, Luis Raposo, Niels van Royen and Michael Maeng

Highlights • CR is beneficial for patients with STEMI. • Acute physiological changes may affect the acute and subacute evaluation of NCLs. • Optimal timing of evaluation and revascularization of NCLs remains to be established. Abstract Nonculprit lesions are frequently observed in patients with ST-segment elevation myocardial infarction. Results from recent randomized clinical trials suggest that complete revascularization after ST-segment elevation myocardial infarction improves outcomes. In this state-of-the-art paper, the authors review these trials and consider how best to determine which nonculprit lesions require revascularization and when this should be performed.

Cardiovascular Marketplace More »
Edwards PASCAL Transcatheter Valve Repair System Receives European Approval For Tricuspid Repair

May 18, 2020 by
Edwards Lifesciences Corporation

Edwards PASCAL Transcatheter Valve Repair System Receives European Approval For Tricuspid Repair

Jeffrey J. Popma, M.D. to Join Medtronic as Vice President and Chief Medical Officer for Coronary, Renal Denervation, and Structural Heart Businesses

May 18, 2020 by
Medtronic

Jeffrey J. Popma, M.D. to Join Medtronic as Vice President and Chief Medical Officer for Coronary, Renal Denervation, and Structural Heart Businesses

Medtronic Congenital Heart Disease Studies Show Strong 10-Year Performance for Melody Transcatheter Pulmonary Valve and Primary Results from the Harmony Pivotal Trial

May 15, 2020 by
Medtronic plc

Medtronic Congenital Heart Disease Studies Show Strong 10-Year Performance for Melody Transcatheter Pulmonary Valve and Primary Results from the Harmony Pivotal Trial

MedAlliance Gains CE Mark Approval for Coronary SELUTION SLR™ Sirolimus Drug Eluting Balloon

May 14, 2020 by
MedAlliance

MedAlliance Gains CE Mark Approval for Coronary SELUTION SLR™ Sirolimus Drug Eluting Balloon

Late-Breaking Clinical Trial Data Underscore Safety And Efficacy Of Boston Scientific S-ICD System

May 08, 2020 by
Boston Scientific

Late-Breaking Clinical Trial Data Underscore Safety And Efficacy Of Boston Scientific S-ICD System

PINNACLE FLX Study of the WATCHMAN FLX™ Left Atrial Appendage Closure Device Presented as Late-Breaking Clinical Trial at HRS 2020 SCIENCE

May 08, 2020 by
Boston Scientific

PINNACLE FLX Study of the WATCHMAN FLX™ Left Atrial Appendage Closure Device Presented as Late-Breaking Clinical Trial at HRS 2020 SCIENCE

CRT POLL

As we resume elective cases who should be tested for COVID-19 prior to the procedures?

The patient

The health care providers

Both the patient and the health care providers

Testing should not be prerequisite for an elective asymptomatic patient

18%
The patient

6%
The health care providers

35%
Both the patient and the health care providers

41%
Testing should not be prerequisite for an elective asymptomatic patient

Show Results

1 2 3 4 5 Next »
1-5 of 30 results

Association of Excessive Speed Reduction with Clinical Factors During Rotational Atherectomy

Apr 28, 2020 by

Kenichi Sakakura, Yousuke Taniguchi, Kei Yamamoto, Hiroshi Wada, ... Hideo Fujita

Association of Excessive Speed Reduction with Clinical Factors During Rotational Atherectomy

Cardiogenic Shock in the Setting of Acute Myocardial Infarction: The Swinging Pendulum of Revascularization

Apr 28, 2020 by
Michael J. Lipinski

Cardiogenic Shock in the Setting of Acute Myocardial Infarction: The Swinging Pendulum of Revascularization

Complete Versus Culprit only Revascularisation in Patients with Cardiogenic Shock Complicating Acute Myocardial Infarction: Incidence and Outcomes from the London Heart Attack Group

Apr 28, 2020 by

Krishnaraj S. Rathod, Sudheer Koganti, Ajay K. Jain, Roby Rakhit, ... Daniel A. Jones

Complete Versus Culprit only Revascularisation in Patients with Cardiogenic Shock Complicating Acute Myocardial Infarction: Incidence and Outcomes from the London Heart Attack Group

Contrast-Induced Kidney Injury: Acute, but Often with Everlasting Consequences

Apr 28, 2020 by

Lorenzo Azzalini

Contrast-Induced Kidney Injury: Acute, but Often with Everlasting Consequences

Coronary Angiography in Patients with Arteria Lusoria via Right Radial Access: A Case Series and Literature Review

Apr 28, 2020 by

Tanawan Riangwiwat, Nath Limpruttidham, Tayebah Mumtaz, James C. Blankenship

Coronary Angiography in Patients with Arteria Lusoria via Right Radial Access: A Case Series and Literature Review

1 2 3 4 5 Next »
1-5 of 30 results

Pre-Emptive Radiofrequency Septal Ablation to Decrease the Risk of Left Ventricular Outflow Tract Obstruction After TMVR

Video Presentations All Presentations »

New Developments in SAVR

May 13, 2020

STEMI in Patients w/ COVID 19: Clinical and Angio Outcomes

May 13, 2020

Out-of-Hospital Cardiac Arrest and COVID-19

May 06, 2020

Long-term Outcomes in Patients With Severely Reduced Left Ventricular Ejection Fraction Undergoing Percutaneous Coronary Intervention vs Cor...

Apr 15, 2020

Early Experience With Cerebral Embolic Protection During Transcatheter Aortic Valve Replacement in the United States

Mar 19, 2020

Long-Term Outcomes of Anticoagulation for Bioprosthetic Valve Thrombosis

Mar 12, 2020

CRTonline on Facebook

CRT Meeting

CRTonline on Twitter

Tweets by @CRT_meeting

Explore the Site

Stay Connected

CRT Group Foundation is a not for profit corporation dedicated to providing educational services in the field of cardiology through the website, CRTonline.org and the Cardiovascular Research Technologies (CRT) annual symposium. CRT focuses on the advances and changes in the field of cardiovascular medicine. CRT is designed to provide access to the world’s leading clinicians and the latest research in order to improve practice and treatment outcomes for a variety of health care professionals.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details

* Required
* First Name:
* Last Name:
Member ID:
* Phone Number:
* Email:
* Enter code:

* Message:

TCT 2020 Goes Virtual

TCT 2020 Goes Virtual

TAVR Appears to Be Reasonable Treatment for Higher-Risk Patients with Bicuspid Aortic Stenosis

DCBs Show Good Results in BMS-ISR, Less Effective in DES-ISR

DCBs Show Good Results in BMS-ISR, Less Effective in DES-ISR https://www.crtonline.org/news-detail/dcbs-show-good-results-in-bms-isr-less-effective-i

Study Finds No Benefit of Hydroxychloroquine or Chloroquine in COVID-19 Treatment

Study Finds No Benefit of Hydroxychloroquine or Chloroquine in COVID-19 Treatment https://www.crtonline.org/news-detail/study-finds-no-benefit-of-hydroxychloroquine-chlor

Complete Revascularization Tops Culprit-Lesion-Only Strategy in Systematic Review

Complete Revascularization Tops Culprit-Lesion-Only Strategy in Systematic Review https://www.crtonline.org/news-detail/complete-revascularization-tops-culprit-lesion-onl

In The News See More

COVID-19 Series: Focused Discussions View More

Latest Videos See All Interviews »

Journal Watch More »

Cardiovascular Marketplace More »

CRT POLL

Video Presentations All Presentations »

CRTonline on Facebook

CRTonline on Twitter

Explore the Site

Stay Connected

Thank you